Ravelli, 2005, Preliminary diagnostic guidelines for macrophage activation syndrome complicating systemic juvenile idiopathic arthritis, J Pediatr, 146, 598, 10.1016/j.jpeds.2004.12.016
Davi, 2011, an international consensus survey of diagnostic criteria for macrophage activation syndrome in systemic juvenile idiopathic arthritis, J Rheumatol, 38, 764, 10.3899/jrheum.100996
Deane, 2010, Macrophage activation syndrome in autoimmune disease, Int Arch Immunol, 153, 109, 10.1159/000312628
Canna, 2012, Not all hemophagocytes are created equally: appreciating the heterogeneity of the hemophagocytic syndromes, Curr Opin Rheumatol, 24, 113, 10.1097/BOR.0b013e32834dd37e
Filho, 2008, Síndrome de ativação macrofágica secundária à infecção aguda pelo vírus Epstein‐Barr, Rev Bras Reumatol, 48, 179, 10.1590/S0482-50042008000300009
Cassidy, 2011, 45, 674
Parodi, 2009, Macrophage activation syndrome in juvenile systemic lupus erythematosus: a multinational multicenter study of thirty‐eight patients, Arthr & Rheumat, 60, 3388, 10.1002/art.24883
Weitzman, 2011, Approach to hemophagocytic syndromes, Am Soc Hematol, 1, 178, 10.1182/asheducation-2011.1.178
Miettunen, 2011, Successful treatment of severe paediatric rheumatic disease‐associated macrophage activation syndrome with interleukin‐1 inhibition therapy: case series with 12 patients, Rheumatol, 50, 417, 10.1093/rheumatology/keq218
Henter, 2007, Review HLH‐2004: diagnostic and therapeutic guidelines for hemophagocytic lymphohistiocytosis, Pediatr Blood Cancer, 48, 124, 10.1002/pbc.21039
Jordan, 2011, How I treat hemophagocytic lymphohistiocytosis, Blood, 118, 4041, 10.1182/blood-2011-03-278127
Shiraishi, 2011, Treatment choice of immunotherapy or further chemotherapy for epstein‐barr virus‐associated hemophagocytic lymphohistiocytosis, Pediatr Blood Cancer, 59, 265, 10.1002/pbc.24039
Henter, 2002, Treatment of hemophagocytic lymphohistiocytosis with HLH‐94, Blood, 100, 2367, 10.1182/blood-2002-01-0172